LioCyx-M004
- Generic Name
- LioCyx-M004
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor.
- Associated Conditions
- -
- Associated Therapies
- -
Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)
- First Posted Date
- 2021-02-09
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Lion TCR Pte. Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT04745403
- Locations
- 🇸🇬
Singapore General Hospital, Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath